Sunmax Biotechnology Co Ltd (4728) — Cash Flow Reinvestment Rate
Sunmax Biotechnology Co Ltd (4728) has a Cash Flow Reinvestment Rate of 1.35x as of September 2025, reinvesting NT$217.44 Million (capex NT$17.44 Million plus investments NT$-200.00 Million) from operating cash flow of NT$160.84 Million. Explore Sunmax Biotechnology Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sunmax Biotechnology Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Sunmax Biotechnology Co Ltd across 9 annual periods. Also explore 4728 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sunmax Biotechnology Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Sunmax Biotechnology Co Ltd. For live market cap and broader valuation context, see 4728 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.14x | NT$53.71 Million | NT$397.37 Million | NT$36.61 Million | ▼ -9.3% |
| 2023 | 0.15x | NT$126.43 Million | NT$848.56 Million | NT$110.39 Million | ▼ -86.3% |
| 2022 | 1.09x | NT$372.50 Million | NT$342.97 Million | NT$152.03 Million | ▼ -10.5% |
| 2021 | 1.21x | NT$295.11 Million | NT$243.28 Million | NT$255.43 Million | ▲ +195.3% |
| 2020 | 0.41x | NT$158.97 Million | NT$386.97 Million | NT$130.10 Million | ▲ +2.5% |
| 2019 | 0.40x | NT$116.05 Million | NT$289.51 Million | NT$13.68 Million | ▼ -56.3% |
| 2018 | 0.92x | NT$92.50 Million | NT$100.83 Million | NT$4.72 Million | ▼ -72.0% |
| 2017 | 3.28x | NT$121.50 Million | NT$37.09 Million | NT$3.15 Million | ▲ +514.9% |
| 2016 | 0.53x | NT$8.83 Million | NT$16.58 Million | NT$4.73 Million | — |